MMG names Chris Middleton vice president of technology

Friday, February 10, 2012 11:47 AM

MMG, a global clinical trials patient recruitment group, part of Ketchum, has appointed Chris Middleton vice president of technology.

Middleton will oversee all new technology products and application, service and infrastructure development. He will provide leadership and strategic direction for MMG's portfolio of technology-based patient recruitment efforts.

Middleton is a software industry veteran with a track record in complex software development across the healthcare, privacy, biometrics and enterprise integration industries, both in the U.S. and internationally. In addition to being a software architect and technology manager for companies such as CGI-AMS, Software AG, Deutsche Post DHL and Daon, Middleton has held leadership positions for software startups and founded Scaled Objects in 2007.

"Chris' passion for developing novel technology solutions that bridge gaps between patients and the services they need is perfectly suited for achieving MMG's aggressive goals for innovating and meeting our clients' needs,” said John Benbrook, CEO of MMG.

Share:          
CWWeekly

April 27

Doctors, patients in the U.S. and U.K. agree: Mobile health apps are good for our health

AARP teams with Georgia Tech's HomeLab, Pfizer and UnitedHealthcare to test wearables with consumers 50+

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs